| abstract |
This application is about specific binding objects for binding to PD-L1. The specific binding object preferably includes a PD-L1 antigen binding address located within a structural loop of a constant domain of the specific binding object. The specific combination object is used in, for example, cancer treatment, infectious diseases, inflammation, inflammation-related diseases and conditions, and inflammatory diseases. |